Chronic Inflammatory Disease Clinical Trial
— SCORIC-AOfficial title:
Chronic Inflammatory Rheumatism: Management of Comorbidities in Ambulatory Medicine
Identification of factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes
Status | Recruiting |
Enrollment | 400 |
Est. completion date | February 11, 2024 |
Est. primary completion date | February 11, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility | Inclusion Criteria: - Patient cohort : - men and women over 18 years of age - Informed volunteers who have consented to participate in the study - have rheumatoid arthritis, spondyloarthritis or psoriatic arthritis - have been hospitalised in a day hospital in the rheumatology department of the Grenoble-Alpes University = SCORIC cohort of the department - Cohort of referring physicians : - volunteers who received informed information and consented to participate in the study - be the referring physician of a patient of the SCORIC cohort of the rheumatology department of the South Hospital of the CHU Grenoble-Alpes Exclusion Criteria: - Patient cohort : - psychiatric pathologies or history of behavioural disorders - persons referred to in articles L1121-5 to L1121-8 of the Public Health Code - persons under guardianship or curatorship - not affiliated to the social security system - minors - Refusal to participate by the patient and/or unreturned questionnaire - Cohort of referring physicians: - the physician is no longer the patient's referring physician - refusal of the doctor to participate and/or questionnaire not returned |
Country | Name | City | State |
---|---|---|---|
France | CHU Grenoble Alpes | Grenoble |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Grenoble |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes, through questionnaires | Identification of the factors limiting compliance with the recommendations established during the evaluation of the SCORIC population by the rheumatology department of the CHU Grenoble Alpes | 1 day | |
Secondary | Elements limiting the good ambulatory follow-up, according to the patients | Description by the patients through the questionnaire of the elements limiting the good ambulatory follow-up | 1 day | |
Secondary | Elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes, according to the patients | Description by the referring physicians through the questionnaire of the elements limiting the applicability of the recommendations issued by the rheumatology department of the CHU Grenoble Alpes | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04327752 -
Skin Adverse Reactions Occuring in Children Treated by Biotherapy for Chronic Inflammatory Disease
|
||
Recruiting |
NCT04334031 -
Deployment o the Multidisciplinary Prospective Cohort Imminent
|
N/A | |
Active, not recruiting |
NCT02332460 -
Infusion Related Reactions in Patients Receiving Infliximab
|
||
Terminated |
NCT05323110 -
Study of Intravenously Administered Anti-LIGHT Monoclonal Antibody CBS001 in Healthy Volunteers
|
Phase 1 |